Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Pediatric Blood & Cancer|July 30, 2026
How Clinicians Manage Sleep During Inpatient Hospitalization Following Pediatric Hematopoietic Stem Cell TransplantationLydia Chevalier, Eva Robinson, Edie Weller, et al.
Pediatric Blood & Cancer|August 11, 2020
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy ConsortiumMichael A Pulsipher, Leslie E Lehmann, Alison A Bertuch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemiaIrene M Ghobrial, Aldo Roccaro, Fangxin Hong, et al.
Blood|May 4, 2011
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker ConsortiumGilles Salles, Daphne de Jong, Wanling Xie, et al.
Blood|October 18, 2002
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaPaul G Richardson, Robert L Schlossman, Edie Weller, et al.
Blood|March 16, 2025
Lymphoid malignancies in patients with Shwachman-Diamond syndromeHelen D Reed, Hyunwoo Do, Edie Weller, et al.
Blood|February 19, 2017
Prognostic role of circulating exosomal miRNAs in multiple myelomaSalomon Manier, Chia-Jen Liu, Hervé Avet-Loiseau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jawNoopur Raje, Sook-Bin Woo, Karen Hande, et al.
Haematologica|February 11, 2014
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumBirgitta Sander, Daphne de Jong, Andreas Rosenwald, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone diseaseSonia Vallet, Siddhartha Mukherjee, Nileshwari Vaghela, et al.
Pageof 8